Pay in 4 interest-free payments of $6.85 Learn more
Ships within 48 hours · Estimated delivery Sep 6 - Sep 11
F.MaesM.WalkerA
It is a first-in-class, multitarget inhibitor of the PI3K/AKT/mTOR pathway, filed under priority review for HR-positive, HER2-negative, PIK3CA wild-type advanced breast cancer in patients who have progressed after CDK4/6 inhibitor and aromatase inhibitor therapy
If you use sterile water, you should draw all doses into individual syringes immediately after reconstitution and store them separately
Within complex I, cIAPs and LUBAC trigger RIPK1 ubiquitination leading to stabilization of complex I, which in turn induces recruitment of TGF--activating kinase 1 (TAK1), TAK1-binding protein 2 (TAB2), and TAB3 to generate TAK1-TAB2-TAB3 complex (Liu et al., 2021
doi:10.1136/bmjopen-2014-006964
US$ 28.21
US$ 28.11
US$ 20.73
US$ 28.73
US$ 29.29
